Butterfly Network Advances AI-Powered Ultrasound for Aortic Screening

Butterfly Network Inc. (NYSE:BFLY) is one of the most promising penny stocks under $5. On August 5, Butterfly Network announced advancements in AI-powered screening for aortic valve and aorta conditions. These developments include new research and the launch of a training tool called Butterfly ScanLab.

A study by Tufts Medical Center, published in the European Heart Journal – Imaging Methods and Practice, highlighted the potential of ML models to enable earlier detection of aortic stenosis/AS. The research showed that an ML model, when fine-tuned for use on Butterfly iQ+ handheld ultrasound devices, achieved an AUROC of 0.94 for differentiating between no aortic stenosis and any degree of the condition.

Aortic stenosis, which is a narrowing of the aortic valve, affects over 13% of Americans aged 75 and older and is often undiagnosed until it becomes advanced. Undiagnosed cases are associated with a higher risk of procedures, worse outcomes, and increased healthcare costs.

Butterfly Network Inc. (NYSE:BFLY) develops, manufactures, and commercializes ultrasound imaging solutions in the US and internationally.

While we acknowledge the potential of BFLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.